Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Dohner H, DiNardo CD, Appelbaum FR, Craddock C, et al. Blood 2024;144:2169-2173.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dohner H, DiNardo CD, Appelbaum FR, Craddock C, et al. Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendations. Blood 2024;144:2169-2173.
PMID: 39133932